Search For "bharat biotech"
Updated : 2 weeks, 3 days ago IST
New Delhi [India], July 22 (ANI): Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, India's indigenous COVID-19 vaccine.
Updated : 1 month ago IST
Mumbai (Maharashtra) [India], July 4 (ANI): Maharashtra Health Minister Rajesh Tope is hopeful and positive about the indigenous COVID-19 vaccine after the Indian Council of Medical Research (ICMR) DG Balram Bhargava informed that the vaccine trial will begin by July 7 on Friday.
New Delhi [India], July 3 (ANI) The Indian Council of Medical Research (ICMR) DG Balram Bhargava has written a letter to Bharat Biotech and principal investigators of medical colleges to complete the trial procedure of indigenous COVID-19 vaccine in a fast track method, so that results of
Updated : 1 month, 1 week ago IST
New Delhi [India], June 30 (ANI): The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human clinical trials to develop an indigenous vaccine for COVID-19 -- in the name COVAXIN.
Hyderabad (Telangana) [India], June 30 (ANI): Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
Updated : 3 months ago IST
New Delhi, May 9 [India], May 9 (ANI): The Indian Council of Medical Research (ICMR) on Saturday announced that it has partnered with the Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for COVID-19 using the virus strain isolated at the National Institute o
Updated : 4 months ago IST
Hyderabad (Telangana) [India], Apr 4 (ANI): Bharat biotech is developing a one drop COVID-19 intranasal vaccine 'CoroFlu' using a proven safety platform.
Updated : 2 years, 6 months ago IST
New Delhi [India], Jan 25 (ANI-BusinessWire India): Bharat Biotech on Thursday announced that the World Health Organisation (WHO Geneva) has awarded prequalification to the developing world's first rotavirus vaccine, ROTAVAC.